Cryopak Industries Inc.
TSX VENTURE : CYK

Cryopak Industries Inc.

June 23, 2005 09:00 ET

Cryopak Enters European Pharmaceutical Market with Sanofi Pasteur

VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - June 23, 2005) - Cryopak Industries Inc. (TSX VENTURE:CYK) today announced a new agreement to provide Sanofi Pasteur, the vaccines business of the Sanofi-Aventis Group, in France with critical cold chain components for international shipments of its temperature sensitive vaccines.

"The success that we have enjoyed in our pharmaceutical package business over the past twelve months is due to the professionalism and dedication of our team and their relentless drive to satisfy our customers. As well, our patented Flexible Ice™ Blanket provides a distinct competitive advantage for us in developing package solutions that ensure thermal protection for our customers' vaccine shipments," stated Martin Carsky, President and CEO of Cryopak. "We are pleased to be able to work with first class companies such as Sanofi both domestically and abroad," added Mr. Carsky.

About Sanofi-Aventis

The Sanofi-Aventis Group is the world's third-largest pharmaceutical company, ranking number one in Europe. Backed by a world-class R&D organization, Sanofi-Aventis is developing leading positions in seven major therapeutic areas: cardiovascular disease, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine, and vaccines. The Sanofi-Aventis Group is listed in Paris (EURONEXT:SAN) and in New York (NYSE:SNY). Sanofi Pasteur, the vaccines business of the Sanofi-Aventis Group, sold nearly a billion doses of vaccine in 2004, making it possible to protect more than 500 million people across the globe, which is about 1.4 million per day. The company offers the broadest range of vaccines, providing protection against 20 bacterial and viral diseases. For more information, please visit: www.sanofipasteur.com.

About Cryopak

With ISO 9001:2000 certified facilities in Vancouver and Montreal, we are a leading provider of temperature-controlling products and solutions serving global pharmaceutical companies, as well as fine North American retailers and consumer goods companies. In our pharmaceutical business we engineer solutions and supply products that help our customers safely transport their temperature sensitive vaccines. In our retail business, we develop, manufacture and sell reusable ice substitutes, flexible hot and cold compresses, reusable gel ice and instant hot and cold packs. These products are marketed under such popular brand names as Ice-Pak™, Flexible Ice™ Blanket, Simply Cozy®, and Flex Pak™. We also manufacture these same products under private label for many well-known consumer goods companies. Our shares are listed on the TSX Venture Exchange under the symbol CYK. For more information about Cryopak, please visit our website address at: www.cryopak.com.

ON BEHALF OF THE BOARD OF DIRECTORS

Martin Carsky, President and CEO


Contact Information

  • Cryopak Industries Inc.
    Martin Carsky
    President and CEO
    1-800-667-2532
    www.cryopak.com